https://www.selleckchem.com/pr....oducts/Temsirolimus.
Finally, we consider potential therapeutic avenues that target TRM cells to augment the antitumor immune response.Dendritic cells (DCs) are professional antigen-presenting cells (APCs) of the immune system. They capture foreign antigens and can present them to lymphocytes, that is, T cells and B cells, to activate them. DCs are the most potent of all immune cells at inducing the adaptive immune system. Thus, the presence of DCs at the anatomical site of the immune challenge is imperative for the immune system to mount an effective
Like
Comment
Share
